Molecular Biology

S.A. Rosenberg, P. Aebersold, K. Cornetta, A. Kasid, et al., "Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction," New England Journal of Medicine, 323:570-78, 1990. Steven A. Rosenberg (National Cancer Institute, Bethesda, Md.): "The practice of medicine in the future may well be transformed as we learn to treat disease not by surgery, radiation, or drugs, but rather by genetic alteration

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

S.A. Rosenberg, P. Aebersold, K. Cornetta, A. Kasid, et al., "Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction," New England Journal of Medicine, 323:570-78, 1990.

Steven A. Rosenberg (National Cancer Institute, Bethesda, Md.):
"The practice of medicine in the future may well be transformed as we learn to treat disease not by surgery, radiation, or drugs, but rather by genetic alteration to prevent or modify the disease process. "This paper describes the first successful introduction of foreign genes into humans. This study demonstrates that retroviral-mediated gene transduction is safe and practical for human gene transfer, and lays the basis for clinical protocols using the transfer of genes with therapeutic potential for treating disease.

"The approach is now being extended to the cancer treatment by using the gene for tumor necrosis factor transduced into tumor infiltrating lymphocytes. In addition, the gene for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies